Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-07-19
2008-05-27
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S004300, C530S303000, C530S305000, C530S324000, C930S010000
Reexamination Certificate
active
07378390
ABSTRACT:
Novel insulin precursors and insulin precursor analogs comprising a connecting peptide (mini C-peptide) of preferably up to 15 amino acid residues and comprising at least one Gly are provided. The precursors can be converted into human insulin or a human insulin analog. The precursors will typically have a distance between B27 (atom CG2) and A1 (atom CA) of less than 5 Å.
REFERENCES:
patent: 5304473 (1994-04-01), Belagaje et al.
patent: 5324641 (1994-06-01), Jonassen et al.
patent: 5430016 (1995-07-01), Balschmidt et al.
patent: 5840542 (1998-11-01), Kang et al.
patent: 5962267 (1999-10-01), Shin et al.
patent: 6537806 (2003-03-01), Osborne et al.
patent: 6777207 (2004-08-01), Kjeldsen et al.
patent: EP 0427296 (1991-05-01), None
patent: 0055945 (1982-07-01), None
patent: 0163529 (1991-08-01), None
patent: 0347845 (1993-08-01), None
patent: 0741188 (1996-11-01), None
patent: WO 95/16708 (1995-06-01), None
patent: WO 01/49870 (2001-07-01), None
GenBank Accession #P01311.
GenBank Accession #I48166.
GenBank Accession #INOS.
GenBank Accession #INHY.
Bullesbach, E. E., “Semisynthesis of a Shortened Open-Chain Proinsulin”, Tetrahedron Letters, 1982, vol. 23, No. 18, pp. 1877-1880.
Chan, S. J. et al., “Biosynthesis and Periplasmic Segregation of Human Proinsulin inEscherichia coli”, Proc. Natl. Acad. Sci., 1981, vol. 78, No. 9, pp. 5401-5405.
Docherty, K. et al., “Proinsulin Endopeptidase Substrate Specificities Defined by Sitedirected Mutagenesis of Proinsulin”, Journal of Biological Chemistry, 1989, vol. 264, No. 31, pp. 18335-18339.
Jonasson, P. et al., “Single-step Trypsin Cleavage of a Fusion Protein to Obtain Human Insulin and its C Peptide”, Eur. J. Biochem., 1996, vol. 236, pp. 656-661.
Kjeldsen, T., “Yeast Secretory Expression of Insulin Precursors”, Appl. Microbiol. Biotechnol., 2000, vol. 54, pp. 277-286.
Pfeffer, S. R. et al., “Biosynthetic Protein Transport and Sorting by the Endoplasmic Reticulum and Golgi”, 1987, vol. 56, pp. 829-852.
Shin, C. S. et al., “Enhanced Production of Human Mini-Proinsulin in Fed-Batch Cultures at High Cell Density ofEscherichia coliBL21 (DE3)[pET-3aT2M2]”, Biotechnol. Prog., 1997, vol. 13, pp. 249-257.
Taylor, N. A. et al., “Sequence Requirements for Processing of Proinsulin in Transfected Mouse Pituitary AtT20 Cells”, Biochem. J., 1992, vol. 286, pp. 619-622.
Thim, L. et al., “Secretion and Processing of Insulin Precursors in Yeast”, Proc. Natl. Acad. Sci., 1986, vol. 83, pp. 6766-6770.
Wetzel, R. et al., “Expression inEscherichia coliof a Chemically Synthesized Gene for a “Mini-C” Analog of Human Proinsulin”, Gene, 1981, vol. 16, pp. 63-71.
Chang, S-G et al., “Human Insulin Production from a Novel Mini-Proinsulin which has High Receptor-Binding Activity”, Biochem. J., 1998, vol. 329, pp. 631-635.
Kjeldsen Thomas Børglum
Ludvigsen Svend
Gupta Anish
Ha Julie
Novo Nordisk A S
Walker Shelby J.
LandOfFree
Method for making insulin precursors and insulin precursor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for making insulin precursors and insulin precursor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for making insulin precursors and insulin precursor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3987415